{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T08:54:07Z","timestamp":1781686447349,"version":"3.54.5"},"reference-count":17,"publisher":"Norwegian Medical Association","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"DOI":"10.4045\/tidsskr.20.0692","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T10:21:00Z","timestamp":1616494860000},"source":"Crossref","is-referenced-by-count":0,"title":["Tiltak ved akutt forverring av hidrosadenitt"],"prefix":"10.4045","volume":"141","author":[{"given":"Ludvik Hovda","family":"Lien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8ystein","family":"Grimstad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thrasyvoulos","family":"Tzellos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","published-online":{"date-parts":[[2021,3,22]]},"reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"Zouboulis\u00a0CC, Desai\u00a0N, Emtestam\u00a0L et al. European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa. J Eur Acad Dermatol Venereol 2015; 29: 619\u201344. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25640693&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fjdv.12966","DOI":"10.1111\/jdv.12966"},{"key":"ref=2","unstructured":"Goldburg\u00a0SR, Strober\u00a0BE, Payette\u00a0MJ. Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol 2020; 82: 1045\u201358. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=31604104&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.jaad.2019.08.090"},{"key":"ref=3","unstructured":"Danielsen K, Tzellos T, Antonsen OH et al. Veileder for behandling av hidradenitis suppurativa i Norge. Oslo: Norsk forening for dermatologi og venerologi, 2019. https:\/\/beta.legeforeningen.no\/foreningsledd\/fagmed\/norsk-forening-for-dermatologi-og-venerologi\/aktuelt\/2019\/veileder-for-behandling-av-hidradenitis-suppurativa-i-norge\/ Lest 17.12.2019."},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Hendricks\u00a0AJ, Hsiao\u00a0JL, Lowes\u00a0MA et al. A comparison of international management guidelines for hidradenitis suppurativa. Dermatology 2021; 237: 81\u201396. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=31645040&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1159%2F000503605","DOI":"10.1159\/000503605"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Grimstad\u00a0\u00d8, Tzellos\u00a0T, Dufour\u00a0DN et al. Evaluation of medical and surgical treatments for hidradenitis suppurativa using real-life data from the Scandinavian registry (HISREG). J Eur Acad Dermatol Venereol 2019; 33: 1164\u201371. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=30451320&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fjdv.15353","DOI":"10.1111\/jdv.15353"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Tzellos\u00a0T, Zouboulis\u00a0CC. Review of comorbidities of hidradenitis suppurativa: Implications for daily clinical practice. Dermatol Ther (Heidelb) 2020; 10: 63\u201371. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=31955366&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007%2Fs13555-020-00354-2","DOI":"10.1007\/s13555-020-00354-2"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Kimball\u00a0AB, Okun\u00a0MM, Williams\u00a0DA et al. Two phase 3 trials of adalimumab for hidradenitis suppurativa. N Engl J Med 2016; 375: 422\u201334. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27518661&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1056%2FNEJMoa1504370","DOI":"10.1056\/NEJMoa1504370"},{"key":"ref=8","unstructured":"Beslutningsforum. Beslutning i beslutningsforum for nye metoder: Adalimumab (Humira). https:\/\/nyemetoder.no\/metoder\/adalimumab-humira Lest 16.12.2019."},{"key":"ref=9","unstructured":"Garc\u00eda-Mart\u00ednez\u00a0FJ, Vilarrasa Rull\u00a0E, Salgado-Boquete\u00a0L et al. Intralesional corticosteroid injection for the treatment of hidradenitis suppurativa: a multicenter retrospective clinical study. J Dermatolog Treat 2019; 31: 1\u20135. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=31402725&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1080%2F09546634.2019.1655524"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Riis\u00a0PT, Boer\u00a0J, Prens\u00a0EP et al. Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): A case series. J Am Acad Dermatol 2016; 75: 1151\u20135. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27692735&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.jaad.2016.06.049","DOI":"10.1016\/j.jaad.2016.06.049"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Fajgenbaum\u00a0K, Crouse\u00a0L, Dong\u00a0L et al. Intralesional triamcinolone may not be beneficial for treating acute hidradenitis suppurativa lesions: A double-blind, randomized, placebo-controlled trial. Dermatol Surg 2020; 46: 685\u20139. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=31490300&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097%2FDSS.0000000000002112","DOI":"10.1097\/DSS.0000000000002112"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Garelik\u00a0J, Babbush\u00a0K, Ghias\u00a0M et al. Efficacy of high-dose intralesional triamcinolone for hidradenitis suppurativa. Int J Dermatol 2021; 60: 217\u201321. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32808305&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fijd.15124","DOI":"10.1111\/ijd.15124"},{"key":"ref=13","unstructured":"Salvador-Rodr\u00edguez\u00a0L, Arias-Santiago\u00a0S, Molina-Leyva\u00a0A. Ultrasound-assisted intralesional corticosteroid infiltrations for patients with hidradenitis suppurativa. Sci Rep 2020; 10: 13363. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32770058&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038%2Fs41598-020-70176-x"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Kohorst\u00a0JJ, Baum\u00a0CL, Otley\u00a0CC et al. Surgical management of hidradenitis suppurativa: Outcomes of 590 consecutive patients. Dermatol Surg 2016; 42: 1030\u201340. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27340739&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097%2FDSS.0000000000000806","DOI":"10.1097\/DSS.0000000000000806"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Blok\u00a0JL, Boersma\u00a0M, Terra\u00a0JB et al. Surgery under general anaesthesia in severe hidradenitis suppurativa: a study of 363 primary operations in 113 patients. J Eur Acad Dermatol Venereol 2015; 29: 1590\u20137. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25589154&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fjdv.12952","DOI":"10.1111\/jdv.12952"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Dahmen\u00a0RA, Gkalpakiotis\u00a0S, Mardesicova\u00a0L et al. Deroofing followed by thorough sinus tract excision: a modified surgical approach for hidradenitis suppurativa. J Dtsch Dermatol Ges 2019; 17: 698\u2013702. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=31219670&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fddg.13875","DOI":"10.1111\/ddg.13875"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"van der Zee\u00a0HH, Prens\u00a0EP, Boer\u00a0J. Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. J Am Acad Dermatol 2010; 63: 475\u201380. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20708472&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.jaad.2009.12.018","DOI":"10.1016\/j.jaad.2009.12.018"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T08:07:47Z","timestamp":1781683667000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2021\/03\/klinisk-oversikt\/tiltak-ved-akutt-forverring-av-hidrosadenitt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,22]]},"references-count":17,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,3,23]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.20.0692","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,22]]}}}